Clinical Scorecard: Comparative Effectiveness of Various Acupoint Stimulation Techniques in Treating Primary Insomnia: A Systematic Review and Network Meta-Analysis
At a Glance
Category
Detail
Condition
Primary insomnia (PI), a chronic sleep disorder characterized by difficulty initiating or maintaining sleep without other medical or psychiatric causes
Key Mechanisms
Acupoint stimulation therapies (e.g., body acupuncture, electroacupuncture, moxibustion, auricular acupressure) targeting specific acupoints to improve sleep quality and related symptoms
Target Population
Adults (≥18 years) diagnosed with primary insomnia based on standardized diagnostic criteria (DSM, ICD, ICSD, CCMD, or TCM classifications)
Care Setting
Clinical settings offering non-pharmacological interventions for insomnia, including acupuncture clinics and integrative medicine centers
Key Highlights
Network meta-analysis of 95 RCTs involving 7,628 patients comparing 14 acupoint stimulation therapies and 108 major acupoints
Body acupuncture combined with electroacupuncture ranked highest for total effective rate; moxibustion combined with tuina most effective in reducing total PSQI score
Electroacupuncture combined with auricular acupressure showed superior improvement across all six PSQI subcomponents
Guideline-Based Recommendations
Diagnosis
Diagnose primary insomnia using standardized criteria such as DSM-4, DSM-5, ICD-10, ICSD-3, CCMD versions, or TCM classifications
Management
Consider individualized acupoint stimulation therapies as non-pharmacological treatment options for primary insomnia
Use combinations such as body acupuncture with electroacupuncture or moxibustion with tuina to optimize efficacy
Incorporate auricular acupressure combined with electroacupuncture to improve multiple sleep quality domains
Monitoring & Follow-up
Assess treatment effectiveness using total effective rate (TER) and Pittsburgh Sleep Quality Index (PSQI) including its six subcomponents
Monitor changes in PSQI scores from baseline to post-treatment to evaluate clinical response
Risks
Tolerability and long-term efficacy of acupoint stimulation therapies remain unclear; monitor for any adverse effects
Pharmacological treatments carry risks of side effects and dependency; acupoint stimulation offers a relatively low incidence of side effects
Patient & Prescribing Data
Adults with primary insomnia diagnosed by standardized criteria
Acupoint stimulation therapies demonstrate significant efficacy in improving sleep quality and symptoms with low side effect profiles; treatment should be individualized based on acupoint compatibility and patient response
Clinical Best Practices
Select acupoints based on prevalent patterns such as Shenmen (HT7), Baihui (GV20), and Anmian (EX-HN22) for body acupuncture
Utilize commonly used ear points including Shenmen (TF4), Xin (CO15), and Pizhixia (AT4) for auricular acupressure
Employ combination therapies (e.g., body acupuncture plus electroacupuncture, moxibustion plus tuina) to maximize treatment outcomes
Use validated outcome measures like PSQI and TER to guide treatment adjustments
Consider patient preferences and clinical context to individualize acupoint stimulation protocols
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
